ANNUAL MEETING ABSTRACT SUBMISSION

Abstract Submission Deadline: November 22, 2023
 
Complete the following form to submit your abstract for the STA 2024 Annual Meeting, held at the Royal Sonesta Galleria in Houston, TX, from January 11-14, 2023. One abstract per form. Please see submission guidelines below.
 
Submission Guidelines:
  • Abstracts may not have been published previously.
  • Abstracts should be brief, typically less than 600 words.
  • Submit a Microsoft Word document in suggested format.
  • Limited to one page with embedded graphics.
  • Submitted via the internet using the online submission form.
  • Abstracts are peer-reviewed according to the following criteria: originality/good design, scientific impact/careful analysis, quality/clear writing.
  • Authors will be notified of review decision via email.
  • Presenting authors are required to pay conference registration and expenses.
CLICK HERE to view a sample PDF of acceptable abstract formatting.

CONTACT AUTHOR INFORMATION

PRESENTING AUTHOR INFORMATION
(If contact author and presenting author
are the same, please note as "same")

ABSTRACT TITLE AND SUBMISSION


CLICK HERE to view a sample PDF of acceptable abstract formatting.

POSTERS IN A MINUTE PARTICIPATION

Posters in a Minute

In addition to the printed poster displayed throughout the meeting, we are asking the main author to orally present a PDF version of their poster at the main podium in a one-minute summary called “Posters in a Minute”. Our goals are to increase visibility of STA members’ research and to familiarize the audience with the author’s work so they can ask more questions during the traditional breaks with posters.

One “Posters in a Minute” session will be scheduled each day of the meeting. Please make an effort to stand by your poster during the breaks on the day of your summary presentation so you can answer questions. There will not be time for questions during your podium presentation.

Are you interested in participating in the Posters in a Minute session? (specific details on the day/time of your oral presentation will be provided closer to the Annual Meeting) *

DISCLOSURES AND SPECIFICATIONS

STA publishes an annual supplement to A&A of all abstracts presented at STA scientific meetings: *
If human subjects were used, the following statement is agreed to: "My study satisfies the requirements of my institution or organization regarding the use of human subjects in scientific research." *
Definition of Financial Relationship Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria for promotional speakers’ bureau, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. Contracted research includes research funding where the institution gets the grant and manages the fund's and the person is the principal or named investigator on the grant. There is no minimum dollar amount for relationships.

Definition of Ineligible Company An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Providers of clinical service directly to patients are not ineligible companies (unless the provider of clinical service is owned, or controlled by, an ineligible company).
In the past 24 months, have you had a financial relationship with any ineligible company? *
If you have NOT had a financial relationship with an ineligible company, please skip to Statement questions (1-11).
 
If you have had a financial relationship with an ineligible company, please continue to the following question.
 
Please fill out a disclosure for the presenting/lead authors on the abstract to which this applies.
 
* If Employee and/or Owner relationship(s), further action may be required; we will contact you if necessary.
 Company/Institution:Relationship (Owner, Research Grant Site Principal Investigator, Research Grant Overall Principal Investigator, Public Stock Shareholder, Private Stock Shareholder, Scientific/Medical Advisory Board Member, Employee, Corporate Board Member, Consultant, Speakers Bureau, Patent Holder, Other):
Ineligible Company:
Ineligible Company:
Ineligible Company:
Ineligible Company:
Ineligible Company:
Statement 1 I will not accept payments or reimbursements from an ineligible company (any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.) for my role in the planning and delivery of this CME activity. If I am approached by an ineligible company in this regard, I will immediately notify the Society for Technology in Anesthesia. *
Statement 2 Continuing medical education consists of educational activities which serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession. The content of CME is that body of knowledge and skills generally recognized and accepted by the profession as within the basic medical sciences, the discipline of clinical medicine, and the provision of health care to the public. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards. *
Statement 3 Presentations that promote recommendations, treatment, or manners of practicing medicine that are not within the definition of CME, or known to have risks or dangers that outweigh the benefits or known to be ineffective in the treatment of patients are prohibited. Presentations devoted to advocacy of unscientific modalities of diagnosis or therapy are prohibited. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards. *
Statement 4 All recommendations involving clinical medicine in a CME activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection and analysis. If I am a presenter, my presentation will meet these standards, and if I’m a planner, I will not approve any content that does not meet these standards. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet these standards. *
Statement 5 Presentations must give a balanced view of therapeutic options. Use of generic names will contribute to this impartiality. If the CME educational material or content includes trade names, where available trade names from several companies should be used, not just trade names from a single company. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard. *
Statement 6 Educational materials that are a part of this activity, such as slides, abstracts, and handouts, cannot contain any advertising, trade names, or product-group messages, or ineligible company logos. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard. *
Statement 7 The content or format of a CME activity or its related materials must promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company. If I am a presenter, my presentation will meet this standard, and if I’m a planner, I will not approve any content that does not meet this standard. If I am a session chair and/or an abstract discussant, any contribution I make to discussion, will meet this standard. *
Statement 8 The content of the CME activity must not be influenced by any ineligible company. If I am a presenter, my presentation will meet this standard, and if I'm a planner, I will not approve any content that does not meet this standard. *
Statement 9 If I participate in a non-faculty role, such as planner or reviewer, I will recuse myself from planning educational content related to my financial relationships, or alternatively, my educational content decisions will be reviewed by a planner who has no conflict of interest and who has sufficient expertise to plan this activity. *
Statement 10 If I am an abstract reviewer, I will not score any abstracts of which I am an author or which I know to be from my institution. If I have a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am reviewing, I will refrain from scoring that abstract. Additionally, I will base my recommendations for content selection solely on the mean score when I have a financial relationship with a company engaged in producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients and whose products or services are the subject of an abstract I am selecting. *
Society for Technology in Anesthesia (STA)
6737 W Washington St, Ste 4210, Milwaukee, WI 53214
P: (414) 389-8600 | stahq@stahq.org | www.stahq.org